Cancer medication combinations pose unique bioequivalence challenges for generics. Small changes in drug absorption can affect safety and efficacy. Learn how regulators, hospitals, and manufacturers are adapting to ensure affordable cancer care without compromising outcomes.
Generic drugs make up 90% of U.S. prescriptions and save billions annually. Learn how they're made, from reverse engineering the original to strict FDA testing - and why they're just as safe and effective as brand-name drugs.
© 2026. All rights reserved.